TARPLIN, DOWNS & YOUNG, LLC for BIOTECHNOLOGY INDUSTRY ORGANIZATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
**see addendum page PL 111-148 The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation, biosimilars, 340B, disclosure, comparative effectiveness research ***, no specific bill(s), health care reform, Biosimilars, PDUFA and related FDA policies
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Taxation/Internal Revenue Code TAX
PL 111-148 The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation, pharmaceutical tax, therapeautic tax credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Copyright/Patent/Trademark CPT
S. 23 - The America Invents Act; H.R. 1249 - America Invents Act, patent reform ***, no specific bill(s), Intellectual Property
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Medicare/Medicaid MMM
**see addendum page Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference, health care reform, drug implementation, biosimilars, 340B, least costly alternative, Sunshine PL 111-148 The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation S. 668 - Health Care Bureaucrats Elimination Act, IPAB H.R. 452 Medicare Decisions Accountability Act of 2011 (IPAB) H.R. 5 - Protecting Access to Healthcare Act H.R. 8 - American Taxpayer Relief Act of 2012, physician reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Budget/Appropriations BUD
**see addendum page budget resolution, reconciliation, health care reform, deficit reduction H.Con.Res. 112, budget resolution for 2013 H.R. 5872, Sequestration Transparency Act of 2012 H.R. 8, American Taxpayer Relief Act of 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. On Finance; |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | Congressman Billy Tauzin |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. |
Pharmacy PHA
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.